BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 20022616)

  • 1. Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.
    Cefalu WT; Rood J; Pinsonat P; Qin J; Sereda O; Levitan L; Anderson RA; Zhang XH; Martin JM; Martin CK; Wang ZQ; Newcomer B
    Metabolism; 2010 May; 59(5):755-62. PubMed ID: 20022616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation.
    Wang ZQ; Qin J; Martin J; Zhang XH; Sereda O; Anderson RA; Pinsonat P; Cefalu WT
    Metabolism; 2007 Dec; 56(12):1652-5. PubMed ID: 17998017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.
    Anderson RA; Cheng N; Bryden NA; Polansky MM; Cheng N; Chi J; Feng J
    Diabetes; 1997 Nov; 46(11):1786-91. PubMed ID: 9356027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes.
    Albarracin CA; Fuqua BC; Evans JL; Goldfine ID
    Diabetes Metab Res Rev; 2008; 24(1):41-51. PubMed ID: 17506119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats.
    Kim DS; Kim TW; Park IK; Kang JS; Om AS
    Metabolism; 2002 May; 51(5):589-94. PubMed ID: 11979390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women.
    Amato P; Morales AJ; Yen SS
    J Gerontol A Biol Sci Med Sci; 2000 May; 55(5):M260-3. PubMed ID: 10819315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trial.
    Aghdassi E; Arendt BM; Salit IE; Mohammed SS; Jalali P; Bondar H; Allard JP
    Curr HIV Res; 2010 Mar; 8(2):113-20. PubMed ID: 20163347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
    Herrmann BL; Berg C; Vogel E; Nowak T; Renzing-Koehler K; Mann K; Saller B
    Horm Metab Res; 2004 Jan; 36(1):54-61. PubMed ID: 14983408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice.
    Chen WY; Chen CJ; Liu CH; Mao FC
    Diabetes Obes Metab; 2009 Apr; 11(4):293-303. PubMed ID: 18721257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine: a novel approach to the treatment of type 2 diabetes.
    Pijl H; Ohashi S; Matsuda M; Miyazaki Y; Mahankali A; Kumar V; Pipek R; Iozzo P; Lancaster JL; Cincotta AH; DeFronzo RA
    Diabetes Care; 2000 Aug; 23(8):1154-61. PubMed ID: 10937514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats.
    Cefalu WT; Wang ZQ; Zhang XH; Baldor LC; Russell JC
    J Nutr; 2002 Jun; 132(6):1107-14. PubMed ID: 12042418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.
    Cusi K; Consoli A; DeFronzo RA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4059-67. PubMed ID: 8923861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus.
    Anderson RA; Roussel AM; Zouari N; Mahjoub S; Matheau JM; Kerkeni A
    J Am Coll Nutr; 2001 Jun; 20(3):212-8. PubMed ID: 11444416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus.
    Racek J; Trefil L; Rajdl D; Mudrová V; Hunter D; Senft V
    Biol Trace Elem Res; 2006 Mar; 109(3):215-30. PubMed ID: 16632892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes.
    Phielix E; Brehm A; Bernroider E; Krssak M; Anderwald CH; Krebs M; Schmid AI; Nowotny P; Roden M
    Diabetes Obes Metab; 2013 Oct; 15(10):915-22. PubMed ID: 23574533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation of α-linolenic acid improves serum adiponectin levels and insulin sensitivity in patients with type 2 diabetes.
    Gomes PM; Hollanda-Miranda WR; Beraldo RA; Castro AV; Geloneze B; Foss MC; Foss-Freitas MC
    Nutrition; 2015 Jun; 31(6):853-7. PubMed ID: 25933493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial.
    Moreira-Lucas TS; Duncan AM; Rabasa-Lhoret R; Vieth R; Gibbs AL; Badawi A; Wolever TM
    Diabetes Obes Metab; 2017 Jan; 19(1):133-141. PubMed ID: 27717236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients.
    Vanschoonbeek K; Thomassen BJ; Senden JM; Wodzig WK; van Loon LJ
    J Nutr; 2006 Apr; 136(4):977-80. PubMed ID: 16549460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone-induced improvements in insulin sensitivity occur without concomitant changes in muscle mitochondrial function.
    Bajpeyi S; Pasarica M; Conley KE; Newcomer BR; Jubrias SA; Gamboa C; Murray K; Sereda O; Sparks LM; Smith SR
    Metabolism; 2017 Apr; 69():24-32. PubMed ID: 28285649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of nocturnal fatty acid concentrations by bedtime carbohydrate supplement in type 2 diabetes: effects on insulin sensitivity, lipids, and glycemic control.
    Axelsen M; Lönnroth P; Lenner RA; Taskinen MR; Smith U
    Am J Clin Nutr; 2000 May; 71(5):1108-14. PubMed ID: 10799372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.